Enlightenment Research, LLC Moderna, Inc. Transaction History

Enlightenment Research, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $283,368 - $466,032	2,400 New	2,400 $284,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $856,986 - $1.4 Million	-3,795 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $842,110 - $1.84 Million	3,795 New	3,795 $1.46 Million
Q1 2021 May 12, 2021	SELL	$109.18 - $185.98 $2.51 Million - $4.28 Million	-23,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $1.08 Million - $2.8 Million	16,500 Added 253.85%	23,000 $2.4 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $353,210 - $616,525	6,500 New	6,500 $460,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.